Search results
Author(s):
Derek V Exner
Added:
3 years ago
Why Do We Need Risk Stratification Tools?
Sudden death accounts for between 300,000 and 500,000 deaths each year in North America.1 Patients with a history of myocardial infarction (MI) have a four-fold higher risk of sudden death than those without such a history. Most sudden deaths in ambulatory populations result from life-threatening ventricular arrhythmias that lead to a cardiac arrest.2…
View more
Author(s):
Steve Attanasio
,
Raed Al Dallow
,
Sandeep Nathan
Added:
3 years ago
While acute coronary syndromes inclusive of ST-elevation myocardial infarction (STEMI) have been described in patients with polycythemia vera (PCV), optimal pharmacologic and interventional management strategies in the setting of drastically elevated platelet counts remain unclear.1 To our knowledge this is the first reported case of STEMI with massive thrombus burden in a patient with PCV…
View more
Author(s):
Joris van den Hurk
Added:
3 years ago
Cardiovascular disease (CVD) is the most common cause of death worldwide.1 With an estimated 7.6 million global deaths due to coronary heart disease in 2005,2 the size of the burden placed on society cannot be understated. Acute myocardial infarction (AMI), the classic ‘heart attack,’ will be the classification given to many of these deaths. In its most life-threatening form, AMI is identified…
View more
Author(s):
Roland Klingenberg
,
Christian M Matter
,
Danielle Hof
,
et al
Added:
3 years ago
Abstract
The introduction of novel high-sensitivity cardiac troponin (hs-cTn) assays has made it possible to measure cardiac troponin levels that are up to 10-fold lower than those detectable by conventional cardiac troponin (cTn) assays. With such novel assays, an elevated risk of major adverse cardiovascular events was noted across the continuum of cTn levels, with an incremental risk of…
View more
Mario Marzilli
Job title: Professor and Chairman of the Division of Cardiovascular Medicine
Author
Author(s):
Sundeep Kumar
,
Rafey Feroze
,
Farshad Forouzandeh
Added:
11 months ago
Author(s):
Barbara Stähli
Added:
7 months ago
ESC 2023 — Prof Barbara Stähli (University Hospital Zurich, CH) joins us onsite at ESC 23 to outline the findings of the MULTISTARS AMI Trial (NCT03135275).
MULTISTARS AMI aimed to compare the safety and efficacy of two treatment strategies currently performed in clinical practice, immediate complete revascularization versus staged complete revascularization in patients presenting with ST…
View more
Author(s):
Mahesh Anantha Narayanan
,
Santiago Garcia
Added:
3 years ago
Chest pain is one of the most common reasons for an emergency room (ER) visit in the US with almost 6 million ER visits annually.1
According to the fourth universal definition of MI, acute MI (AMI) requires a rise and/or fall in cardiac troponin (cTn) with at least one value above the 99th percentile upper reference limit.2,3 Cardiac troponin I (cTnI) and cardiac troponin T (cTnT) are the…
View more
Author(s):
Stephen Ku
,
Steven V Edelman
Added:
3 years ago
Cardiovascular disease is an important cause of morbidity and mortality in patients with type 1 and especially type 2 diabetes mellitus.1,2 Data from prospective studies suggest that diabetes is associated with a two to fourfold excess risk of coronary heart disease and coronary death.3–5 It was therefore hoped that controlling hyperglycemia would reduce cardiovascular disease incidence and…
View more
Author(s):
Sascha Ott
,
Laura Leser
,
Pia Lanmüller
,
et al
Added:
2 years ago